Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
JAMA Clinical Reviews20 Heinä 2021

Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk

Several new therapeutic drug classes are now available to manage lipid levels. John Wilkins, MD, MS, and Donald Lloyd-Jones, MD, ScM, of the Department of Preventive Medicine and Division of Cardiology at Northwestern University Feinberg School of Medicine, discuss the use of ezetimibe, PCSK-9 inhibitors, bempedoic acid, and icosapent ethyl to manage lipid levels in patients taking statins who require additional LDL lowering.

Related Content:

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(493)

Management of Dyslipidemia

Management of Dyslipidemia

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author A...

20 Heinä 0s

Hip Fractures: Management and Prevention

Hip Fractures: Management and Prevention

Hip fractures are a leading cause of disability and death in older adults. This episode summarizes  risk factors, prevention, and medical and surgical management of  hip fractures. JAMA Deputy Editor ...

16 Heinä 19min

Alcohol-Related Liver Disease

Alcohol-Related Liver Disease

Alcohol-related liver disease is the leading cause of liver-related morbidity and mortality and the most common indication for liver transplant in Europe and the US. Author Aleksander Krag, MD, PhD, o...

6 Heinä 20min

An Overview of Familial Hypercholesterolemia

An Overview of Familial Hypercholesterolemia

Worldwide, heterozygous familial hypercholesterolemia (FH) affects approximately 1 in 250 to 350 individuals. Author James Stein, MD, of the University of Wisconsin School of Medicine and Public Healt...

29 Kesä 10min

Transforming Communication Between Patients and Clinicians

Transforming Communication Between Patients and Clinicians

Patient portal messaging continues to expand across health systems, and it has become an increasingly important method for patient-clinician communication. Authors Michal Mankowski, PhD, assistant pro...

22 Kesä 15min

Low Back Pain: Diagnosis and Treatment

Low Back Pain: Diagnosis and Treatment

Nonspecific low back pain is a leading cause of disability, with most cases lacking a clear anatomic cause. This episode reviews  risk factors, diagnosis, and current  evidence-based treatments for ac...

15 Kesä 26min

Survivors of Cyanotic Congenital Heart Disease

Survivors of Cyanotic Congenital Heart Disease

Cyanotic congenital heart diseases occur in approximately 0.2% of live births in the US, but survival to adulthood is common with current surgical interventions. JAMA Associate Editor David Simel, MD,...

8 Kesä 23min

Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review

Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review

Community-acquired pneumonia (CAP) accounts for 1.4 million emergency department visits and 740 000 hospitalizations annually in the US. Author Andre Kumar, MD, MEd, of Stanford University School of M...

3 Kesä 16min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
utelias-mieli
rss-hereilla
mielipaivakirja
rss-poliisin-mieli
rss-totuuden-liepeilla
docemilia
rss-ylistys-elaimille
rss-lihavuudesta-podcast
hippokrateen-vastaanotolla
rss-kipinoita-podcast
rss-kasvatuspsykologiaa-kaikille
rss-duodecim-lehti
rss-laakaripodi
rss-tiedetta-vai-tarinaa
rss-ilmasto-kriisissa